Fluidigm to Participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference
November 20 2020 - 9:54PM
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology
tools provider with a vision to improve life through comprehensive
health insight, today announced that the company’s management will
participate in the Piper Sandler 32nd Annual Virtual
Healthcare Conference on Tuesday, December 1, and Wednesday,
December 2.
In advance of the virtual conference and investor meetings, a
pre-recorded fireside chat with Chris Linthwaite, President and
CEO, will be made available, Tuesday, November
24, at 10:00 am ET. During the fireside chat, the company
will present updates regarding Fluidigm’s business strategy and
financial performance.
The recording of the company’s fireside chat will be available
in the Events & Presentations section of the company’s investor
website.
About Fluidigm Fluidigm (Nasdaq:FLDM)
focuses on the most pressing needs in translational and clinical
research, including cancer, immunology, and immunotherapy. Using
proprietary CyTOF® and microfluidics technologies, we develop,
manufacture, and market multi-omic solutions to drive meaningful
insights in health and disease, identify biomarkers to inform
decisions, and accelerate the development of more effective
therapies. Our customers are leading academic, government,
pharmaceutical, biotechnology, plant and animal research, and
clinical laboratories worldwide. Together with them, we strive to
increase the quality of life for all. For more information,
visit fluidigm.com.
Fluidigm, the Fluidigm logo, Advanta and CyTOF are trademarks
and/or registered trademarks of Fluidigm Corporation in the United
States and/or other countries. All other trademarks are the sole
property of their respective owners. The Advanta™ Dx
SARS-CoV-2 RT-PCR Assay is for In Vitro
Diagnostic Use. It is for Use under Emergency Use
Authorization Only. Rx Only. Other Fluidigm
products are provided for Research Use Only. Not for use in
diagnostic procedures.
Available InformationWe use our website
(fluidigm.com), investor site (investors.fluidigm.com), corporate
Twitter account (@fluidigm), Facebook page (facebook.com/Fluidigm),
and LinkedIn page (linkedin.com/company/fluidigm-corporation) as
channels of distribution of information about our products, our
planned financial and other announcements, our attendance at
upcoming investor and industry conferences, and other matters. Such
information may be deemed material information, and we may use
these channels to comply with our disclosure obligations under
Regulation FD. Therefore, investors should monitor our website and
our social media accounts in addition to following our press
releases, SEC filings, public conference calls, and
webcasts.
Contact:
Agnes LeeVice President, Investor Relations650 416
7423agnes.lee@fluidigm.com
Fluidigm (NASDAQ:FLDM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Fluidigm (NASDAQ:FLDM)
Historical Stock Chart
From Apr 2023 to Apr 2024